Skip to content
Clinical Trials – home

Center for Mental Health “Prof. N. Shipkovenski” EOOD

Verified siteinfo

Bulgaria Ulitsa Ekzarh Yosif 59, 1000 Sofia, Bulgaria

  • 5 trials recruiting
  • Dementia Alzheimer's type · Schizophrenia · Major depression
  • Adult patients

About Specializations

Center for Mental Health “Prof. N. Shipkovenski” EOOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Dementia Alzheimer's type, Schizophrenia, Major depression, Bipolar disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Neuropsychiatry

The medical center is at the forefront of neuropsychiatry, focusing on innovative treatments for complex mental health conditions. The ongoing research aims to enhance cognitive functions in individuals with psychiatric disorders, particularly schizophrenia.

  • Cognitive Impairment in Schizophrenia
  • Advanced Therapeutics for Mental Health
  • Neurocognitive Enhancement

By exploring the efficacy of novel compounds like RL-007, the center contributes significantly to the development of targeted therapies that address cognitive disorders associated with psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Ekzarh Yosif 591000 SofiaBulgaria
Recruiting now
5 trials
Conditions studied
7
Partner status
Verified site

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

10 clinical trials

Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Seltorexant
  • Sponsor:Janssen Cilag International

Schizophrenia

Recruiting

A study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:GXV813
  • Sponsor:Novartis Pharma AG

Study on ITI-1284 for Treating Agitation in Alzheimer's Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Psychotic disorder+2

Recruiting

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ACP-204 tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.

Bipolar disorder

Not recruiting

Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lumateperone
  • Sponsor:Intra-Cellular Therapies Inc.

Schizophrenia

Not recruiting

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Valbenazine Ditosylate
  • Sponsor:Neurocrine Biosciences Inc.

Cognitive disorder+1

Not recruiting

Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:(2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
  • Sponsor:Recognify Life Sciences Inc.

Study of ACP-204 for Treating Psychosis in Adults with Alzheimer's Disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ACP-204 tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.

Major depression

Not recruiting

Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.